Evaluation of the paclitaxel-ifosfamide-cisplatin (TIP) combination in relapsed and/or metastatic cervical cancer

British Journal of Cancer

Volumn 101, Issue 7, 2009, Pages 1059-1065

  Kosmas, C ^a,d   Mylonakis, N ^a   Tsakonas, G ^a   Vorgias, G ^a   Karvounis, N ^a   Tsavaris, N ^b   Daladimos, T ^a   Kalinoglou, N ^a   Malamos, N ^c   Akrivos, T ^a   Karabelis, A ^a  

^a METAXA CANCER HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c HELENA VENIZELOU HOSPITAL   (Greece)

^d NONE   (Greece)

Author keywords

Cervical cancer; Chemotherapy; Cisplatin; Ifosfamide; Paclitaxel

Indexed keywords

CISPLATIN; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; PACLITAXEL;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ALOPECIA; ANEMIA; ARTHRALGIA; ARTICLE; ASTHENIA; CANCER RELAPSE; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; DIARRHEA; DRUG DOSE REDUCTION; DRUG HYPERSENSITIVITY; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; HEART DISEASE; HEMATURIA; HUMAN; INFECTION; KIDNEY DISEASE; MAGNESIUM BLOOD LEVEL; METASTASIS; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; MUSCULOSKELETAL PAIN; MYALGIA; NAUSEA; NAUSEA AND VOMITING; NEUROLOGIC DISEASE; NEUROPATHY; NEUTROPENIA; PATIENT COMPLIANCE; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; SIDE EFFECT; SQUAMOUS CELL CARCINOMA; THROMBOCYTOPENIA; TREATMENT RESPONSE; UTERINE CERVIX CANCER; VOMITING; WORLD HEALTH ORGANIZATION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; FEMALE; HUMANS; IFOSFAMIDE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PACLITAXEL; UTERINE CERVICAL NEOPLASMS;

EID: 70349693677     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605305     Document Type: Article

References (34)

1. Buda A, Fossati R, Colombo N, Fei F, Floriani I, Gueli Alletti D, Katsaros D, Landoni F, Lissoni A, Malzoni C, Sartori E, Scollo P, Torri V, Zola P, Mangioni C (2005) Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvante Portio) Italian Collaborative Study. J Clin Oncol 23: 4137-4145 (Pubitemid 46211319)
2. Bunnell CA, Thompson L, Buswell L, Berkowitz R, Muto M, Sheets E, Shulman LN (1998) A phase I trial of ifosfamide and paclitaxel with granulocyte-colony stimulating factor in the treatment of patients with refractory solid tumors. Cancer 82: 561-566 (Pubitemid 28112996)
3. Cervellino JC, Araujo CE, Pirisi C, Sanchez O, Brosto M, Rossi R (1990) Ifosfamide and mesna at high doses for the treatment of cancer of the cervix: a GETLAC study. Cancer Chemother Pharmacol 26(Suppl): S1-S3 (Pubitemid 20161568)
4. Choi CH, Kim TJ, Lee SJ, Lee JW, Kim BG, Lee JH, Bae DS (2006) Salvage chemotherapy with a combination of paclitaxel, ifosfamide, and cisplatin for the patients with recurrent carcinoma of the uterine cervix. Int J Gynecol Cancer 16: 1157-1164 (Pubitemid 43886740)
5. Cox DR (1970) The Analysis of Binary Data. Methuen: London, UK
6. Dimopoulos MA, Papadimitriou CA, Sarris K, Aravantinos G, Kalofonos C, Gika D, Gourgoulis GM, Efstathiou E, Skarlos D, Bafaloukos D (2002) Combination of ifosfamide, paclitaxel, and cisplatin for the treatment of metastatic and recurrent carcinoma of the uterine cervix: a phase II study of the Hellenic Cooperative Oncology Group. Gynecol Oncol 85: 476-482
7. Eisenhauer EA, ten Bokkel-Huinik WW, Swenerton KA, Gianni L, Myles J, van der Burg ME, Kerr I, Vermorken JB, Buser K, Colombo N, Bacon M, Santabarbara P, Onetto N, Winograd B, Canetta R (1994) European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion. J Clin Oncol 12: 2654-2666
8. Herod J, Burton A, Buxton J, Tobias J, Luesley D, Jordan S, Dunn J, Poole CJ (2000) A randomised, prospective, phase III clinical trial of primary bleomycin, ifosfamide and cisplatin (BIP) chemotherapy followed by radiotherapy versus radiotherapy alone in inoperable cancer of the cervix. Ann Oncol 9: 1175-1181 (Pubitemid 30783025)
9. Kaplan EL, Meier P (1958) Non-parametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481
10. Kosmas C, Tsavaris N, Polyzos A, Malamos NA, Katsikas M, Antonopoulos MJ (2000a) Phase I study of dose-escalated paclitaxel, ifosfamide, and cisplatin (PIC) combination chemotherapy in advanced solid tumors. Br J Cancer 82: 300-307 (Pubitemid 30045374)
11. Kosmas C, Tsavaris N, Polyzos A, Kalofonos HP, Sepsas E, Malamos NA, Vadiaka M, Dosios T, Antonopoulos MJ (2000b) A phase II study of paclitaxel-ifosfamide-cisplatin (PIC) combination in advanced nonsmall cell lung cancer. Cancer 89: 774-782 (Pubitemid 30658576)
12. Kosmas C, Tsavaris NB, Malamos NA, Vadiaka M, Koufos C (2001) A phase II study of paclitaxel-ifosfamide-cisplatin (PIC) as second-line treatment in relapsed small-cell lung cancer. J Clin Oncol 19: 119-126 (Pubitemid 32063488)
13. Kudelka AP, Winn R, Edwards CL, Downey G, Greenberg H, Dakhil SR, Freedman RS, LoCoco S, Umbreit J, Delmore JE, Arbuck S, Loyer E, Gacrama P, Fueger R, Kavanagh JJ (1997) An update of a phase II study of paclitaxel in advanced or recurrent squamous cell cancer of the cervix. Anticancer Drugs 8: 657-661 (Pubitemid 27404721)
14. Liebmann JE, Fisher J, Teague D (1994) Sequence dependence of paclitaxel (Taxol) combined with cisplatin or alkylators in human cancer cells. Oncol Res 6: 25-31 (Pubitemid 24209924)
15. Lissoni A, Zanetta G, Losa G, Gabriele A, Parma G, Mangioni C (1996) Phase II study of paclitaxel as salvage treatment in advanced endometrial cancer. Ann Oncol 7: 861-863 (Pubitemid 26345880)
16. Lind MJ, McGowan AT, Hadfield JA, Thatcher N, Crowther D, Fox BW (1989) The effect of ifosfamide and its metabolites on intracellular glutathione levels in vitro and in vivo. Biochem Pharmacol 38: 1835-1840 (Pubitemid 19138534)
17. Lissoni AA, Colombo N, Pellegrino A, Parma G, Zola P, Katsaros D, Chiari S, Buda A, Landoni F, Peiretti M, Dell'anna T, Fruscio R, Signorelli M, Grassi R, Floriani I, Fossati R, Torri V, Rulli E (2009) A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study. Ann Oncol 20: 660-665
18. Long III HJ, Bundy BN, Grendys Jr EC, Benda JA, McMeekin DS, Sorosky J, Miller DS, Eaton LA, Fiorica JV (2005) Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group study. J Clin Oncol 23: 4626-4633 (Pubitemid 46224065)
19. McGuire WP, Blessing JA, Moore D, Lentz SS, Photopulos G (1996) Paclitaxel has moderate activity in squamous cervix cancer. J Clin Oncol 14: 792-795
20. Monk BJ, Sill M, McMeekin DS, Cohn DE, Ramondetta L, Boardman CH, Benda J (2008) A randomized phase III trial of four cisplatin (CIS) containing doublet combinations in stage IVB, recurrent or persistent cervical carcinoma: a gynecologic oncology group (GOG) study. J Clin Oncol 20(Suppl); abstract no. LBA5504
21. Monk BJ, Sill MW, Burger RA, Gray HJ, Buekers TE, Roman LD (2009) Phase II trial of bevacizumab in the treatment of persistent or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol 27: 1069-1074
22. Moore DH, Blessing JA, McQuellon RP, Thaler HT, Cella D, Benda J, Miller DS, Olt G, King S, Boggess JF, Rocereto TF (2004) Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 22: 3113-3119 (Pubitemid 41103724)
23. Omura GA, Blessing JA, Vaccarello L, Berman ML, Clarke-Pearson DL, Mutch DG, Anderson B (1997) Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: A Gynecologic Oncology Group study. J Clin Oncol 15: 165-171 (Pubitemid 27020569)
24. Parker RJ, Dabholkar MD, Lee KB, Bostick-Bruton F, Reed E (1993) Taxol effect on cisplatin sensitivity and cisplatin cellular accumulation in human ovarian cancer cells. J Natl Cancer Inst Monogr 15: 83-88
25. Papadimitriou CA, Sarris K, Moulopoulos LA, Fountzilas G, Anagnostopoulos A, Voulgaris Z, Gika D, Giannakoulis N, Diakomanolis E, Dimopoulos M (1999) Phase II trial of paclitaxel and cisplatin in metastatic and recurrent carcinoma of the uterine cervix. J Clin Oncol 17: 761-766 (Pubitemid 29109303)
26. Reed E, Kohn EC, Sarosy G, Dabholkar M, Davis P, Jacob J, Maher M (1995) Paclitaxel, cisplatin, and cyclophosphamide in human ovarian cancer: molecular rationale and early clinical results. Semin Oncol 22(Suppl 6): 90-96
27. Rose PG, Blessing JA, Gershenson DM, McGehee R (1999) Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 17: 2676-2680
28. Rowinsky EK, Chaudhry V, Forastiere AA, Sartorius SE, Ettinger DS, Grochow LB, Lubejko BG, Cornblath DR, Donehower RC (1993) Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: neuromuscular toxicity is dose-limiting. J Clin Oncol 11: 2010-2020 (Pubitemid 23304628)
29. Simon R (1989) Optimal two-stage designs for phase II clinical trials. Control Clin Trials 10: 1-10 (Pubitemid 19099520)
30. Sutton GP, Blessing JA, McGuire WP, Patton T, Look KY (1993) Phase II trial of ifosfamide and mesna in patients with advanced and recurrent squamous carcinoma of the cervix who have never received chemotherapy. Am J Obstet Gynecol 168: 805-807 (Pubitemid 23095999)
31. Thigpen T, Vance RB, Khansur T (1995) The platinum compounds and paclitaxel in the management of carcinomas of the endometrium and the uterine cervix. Semin Oncol 22: 67-75
32. Tsavaris N, Polyzos A, Kosmas C, Giannikos L, Gogas J (1997) A feasibility study of one-hour paclitaxel infusion in solid tumors. Cancer Chemother Pharmacol 40: 353-357 (Pubitemid 27276141)
33. Zanetta G, Fei F, Parma G, Balestrino M, Lissoni A, Gabriele A, Mangioni C (1999) Paclitaxel, ifosfamide and cisplatin (TIP) chemotherapy for recurrent or persistent squamous-cell cervical cancer. Ann Oncol 10: 1171-1174 (Pubitemid 29533565)
34. Zanetta G, Lissoni A, Pellegrino A, Sessa C, Colombo N, Gueli-Alletti D, Mangioni C (1998) Neoadjuvant chemotherapy with cisplatin, ifosfamide and paclitaxel for locally advanced squamous-cell cervical cancer. Ann Oncol 9: 977-980 (Pubitemid 28496706)